0.3401
price up icon10.35%   0.0319
after-market After Hours: .34 -0.000100 -0.03%
loading
Renovaro Inc stock is traded at $0.3401, with a volume of 1.03M. It is up +10.35% in the last 24 hours and down -7.63% over the past month. Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
See More
Previous Close:
$0.3082
Open:
$0.3251
24h Volume:
1.03M
Relative Volume:
0.31
Market Cap:
$58.54M
Revenue:
-
Net Income/Loss:
$-41.23M
P/E Ratio:
-0.4859
EPS:
-0.7
Net Cash Flow:
$-11.54M
1W Performance:
+0.32%
1M Performance:
-7.63%
6M Performance:
-67.30%
1Y Performance:
-74.43%
1-Day Range:
Value
$0.3251
$0.348
1-Week Range:
Value
$0.3013
$0.36
52-Week Range:
Value
$0.264
$2.10

Renovaro Inc Stock (RENB) Company Profile

Name
Name
Renovaro Inc
Name
Phone
45 39179840
Name
Address
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Name
Employee
25
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
RENB's Discussions on Twitter

Compare RENB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RENB
Renovaro Inc
0.3401 69.57M 0 -41.23M -11.54M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Renovaro Inc Stock (RENB) Latest News

pulisher
04:19 AM

Renovaro Inc. Stock Analysis and ForecastHigh-profit capital plays - Autocar Professional

04:19 AM
pulisher
10:41 AM

What analysts say about Renovaro Inc. stockRapidly growing investment returns - Autocar Professional

10:41 AM
pulisher
03:04 AM

What drives Renovaro Inc. stock priceFree Stock Movement Tracking - jammulinksnews.com

03:04 AM
pulisher
Jul 22, 2025

Is Renovaro Inc. a good long term investmentRapid wealth accumulation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Can Renovaro Inc. stock recover from recent declineDaily Breakout Picks - Newser

Jul 21, 2025
pulisher
Jul 17, 2025

What makes Renovaro Inc. stock price move sharplySmart Return Focused Trading - Newser

Jul 17, 2025
pulisher
Jul 17, 2025

Renovaro Biosciences (RENB) Achieves Milestone with Innovative C - GuruFocus

Jul 17, 2025
pulisher
Jul 17, 2025

Revolutionary Dendritic Cell Therapy Slashes Pancreatic Cancer Tumors by 81% in Groundbreaking Study - Stock Titan

Jul 17, 2025
pulisher
Jul 17, 2025

Renovaro Inc (RENB) Stock: A Comprehensive 52-Week Review - investchronicle.com

Jul 17, 2025
pulisher
Jul 16, 2025

How did Renovaro's expenses impact profits in Q2 2025? - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Renovaro Rockets 20% Higher on Legal Drama—Biotech's High-Stakes Merger Showdown - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

Why Renovaro Inc. stock attracts strong analyst attentionFree Stock Market Expert Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Renovaro Inc. stock performs during market volatilityFree Consultation - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Renovaro receives Nasdaq notice for missing annual shareholder meeting - Investing.com Australia

Jul 14, 2025
pulisher
Jul 14, 2025

Renovaro receives Nasdaq notice for missing annual shareholder meeting By Investing.com - Investing.com Nigeria

Jul 14, 2025
pulisher
Jul 14, 2025

Renovaro Biosciences Receives Nasdaq Compliance Notice - TipRanks

Jul 14, 2025
pulisher
Jul 09, 2025

Renovaro BioSciences strengthens balance sheet through debt conversion - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

AI Healthcare Pioneer Renovaro Eliminates $9.7M Debt Through Strategic Conversion to Power Growth - Stock Titan

Jul 09, 2025
pulisher
Jul 09, 2025

Renovaro Biosciences Restructures Debt with Exchange Agreement - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives - The Globe and Mail

Jul 09, 2025
pulisher
Jul 08, 2025

Predictive Oncology enters into $10M share purchase agreement with New Jersey-based firm - The Business Journals

Jul 08, 2025
pulisher
Jul 01, 2025

Renovaro (NASDAQ:RENB) Shares Down 1.3% – Time to Sell? - Defense World

Jul 01, 2025
pulisher
Jun 30, 2025

Renovaro Stock Soars 12.63% on Innovation, Partnerships - AInvest

Jun 30, 2025
pulisher
Jun 29, 2025

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative - GuruFocus

Jun 29, 2025
pulisher
Jun 17, 2025

Renovaro Inc (RENB Stock: A Sea of Opportunity - investchronicle.com

Jun 17, 2025

Renovaro Inc Stock (RENB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Cap:     |  Volume (24h):